BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 18084917)

  • 1. Virtual screening for the discovery of bioactive natural products.
    Rollinger JM; Stuppner H; Langer T
    Prog Drug Res; 2008; 65():211, 213-49. PubMed ID: 18084917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening and its integration with modern drug design technologies.
    Guido RV; Oliva G; Andricopulo AD
    Curr Med Chem; 2008; 15(1):37-46. PubMed ID: 18220761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High impact technologies for natural products screening.
    Koehn FE
    Prog Drug Res; 2008; 65():175, 177-210. PubMed ID: 18084916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated in silico tools for exploiting the natural products' bioactivity.
    Rollinger JM; Langer T; Stuppner H
    Planta Med; 2006 Jun; 72(8):671-8. PubMed ID: 16783689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for efficient lead structure discovery from natural products.
    Rollinger JM; Langer T; Stuppner H
    Curr Med Chem; 2006; 13(13):1491-507. PubMed ID: 16787200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SwissSimilarity 2021 Web Tool: Novel Chemical Libraries and Additional Methods for an Enhanced Ligand-Based Virtual Screening Experience.
    Bragina ME; Daina A; Perez MAS; Michielin O; Zoete V
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of bioactive natural products by pharmacophore-based virtual screening.
    Schuster D; Wolber G
    Curr Pharm Des; 2010 May; 16(15):1666-81. PubMed ID: 20222852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
    Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
    Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent development and application of virtual screening in drug discovery: an overview.
    Hou T; Xu X
    Curr Pharm Des; 2004; 10(9):1011-33. PubMed ID: 15078130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular descriptors and methods for ligand based virtual high throughput screening in drug discovery.
    Pozzan A
    Curr Pharm Des; 2006; 12(17):2099-110. PubMed ID: 16796558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.
    Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D
    Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacognosy and reverse pharmacognosy: a new concept for accelerating natural drug discovery.
    Do QT; Bernard P
    IDrugs; 2004 Nov; 7(11):1017-27. PubMed ID: 15551177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
    Rester U
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of in silico approaches to identify novel bioactive molecules from natural resources.
    Olğaç A; Orhan IE; Banoglu E
    Future Med Chem; 2017 Sep; 9(14):1665-1686. PubMed ID: 28841048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for Identifying Microbial Natural Product Compounds that Target Kinetoplastid RNA Structural Motifs by Homology and De Novo Modeled 18S rRNA.
    Mwangi HN; Muge EK; Wagacha PW; Ndakala A; Mulaa FJ
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based virtual screening: an overview.
    Lyne PD
    Drug Discov Today; 2002 Oct; 7(20):1047-55. PubMed ID: 12546894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.